FDA Says OTC Asthma Inhalers with CFC Banned After Dec 31
The Food and Drug Administration states that users of epinephrine inhalers with chlorofluorocarbon (CFC)-containing epinephrine should plan now to get a prescription for a replacement product because these inhalers will not be made or sold after December 31, 2011. Primatene…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
Mist, marketed by Armstrong Pharmaceutical Inc, is the only such FDA-approved over-the-counter inhaler of this type. According to FDA, this action is in accordance with the Montreal Protocol on Substances that Deplete the Ozone Layer and the phase-out date was announced in November 2008.